Provides accurate and reliable detection of Influenza A and B within 20 minutes, facilitating swift diagnosis and treatment.
Enables healthcare professionals to quickly administer targeted therapies, enhancing patient care.
Streamlines laboratory workflows, increasing efficiency and throughput.
Contributes to higher patient satisfaction by reducing wait times for results.
Supports rapid decision-making in clinical settings, improving patient management and outcomes.
Features an early assay termination option, offering positive results in as little as 20 minutes and negative results in 30 minutes, expediting patient care.
